Your browser doesn't support javascript.
loading
International Pooled Analysis of Leisure-Time Physical Activity and Premenopausal Breast Cancer in Women From 19 Cohorts.
Timmins, Iain R; Jones, Michael E; O'Brien, Katie M; Adami, Hans-Olov; Aune, Dagfinn; Baglietto, Laura; Bertrand, Kimberly A; Brantley, Kristen D; Chen, Yu; Clague DeHart, Jessica; Clendenen, Tess V; Dossus, Laure; Eliassen, A Heather; Fletcher, Olivia; Fournier, Agnès; Håkansson, Niclas; Hankinson, Susan E; Houlston, Richard S; Joshu, Corinne E; Kirsh, Victoria A; Kitahara, Cari M; Koh, Woon-Puay; Linet, Martha S; Park, Hannah Lui; Lynch, Brigid M; May, Anne M; Mellemkjær, Lene; Milne, Roger L; Palmer, Julie R; Ricceri, Fulvio; Rohan, Thomas E; Ruddy, Kathryn J; Sánchez, Maria-Jose; Shu, Xiao-Ou; Smith-Byrne, Karl; Steindorf, Karen; Sund, Malin; Vachon, Celine M; Vatten, Lars J; Visvanathan, Kala; Weiderpass, Elisabete; Willett, Walter C; Wolk, Alicja; Yuan, Jian-Min; Zheng, Wei; Nichols, Hazel B; Sandler, Dale P; Swerdlow, Anthony J; Schoemaker, Minouk J.
Afiliação
  • Timmins IR; Division of Genetics and Epidemiology, The Institute of Cancer Research, London, United Kingdom.
  • Jones ME; Statistical Innovation, AstraZeneca, Cambridge, United Kingdom.
  • O'Brien KM; Division of Genetics and Epidemiology, The Institute of Cancer Research, London, United Kingdom.
  • Adami HO; Epidemiology Branch, National Institute of Environmental Health Sciences, Research Triangle Park, NC.
  • Aune D; Clinical Effectiveness Group, Institute of Health and Society, University of Oslo, Oslo, Norway.
  • Baglietto L; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
  • Bertrand KA; Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, United Kingdom.
  • Brantley KD; Department of Nutrition, Oslo New University College, Oslo, Norway.
  • Chen Y; Department of Research, The Cancer Registry of Norway, Oslo, Norway.
  • Clague DeHart J; Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
  • Clendenen TV; Slone Epidemiology Center at Boston University, Boston, MA.
  • Dossus L; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA.
  • Eliassen AH; Division of Epidemiology, Department of Population Health, NYU Grossman School of Medicine, New York, NY.
  • Fletcher O; School of Community and Global Health, Claremont Graduate University, Claremont, CA.
  • Fournier A; Division of Epidemiology, Department of Population Health, NYU Grossman School of Medicine, New York, NY.
  • Håkansson N; Nutrition and Metabolism Branch, International Agency for Research on Cancer, Lyon, France.
  • Hankinson SE; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA.
  • Houlston RS; Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA.
  • Joshu CE; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, United Kingdom.
  • Kirsh VA; UVSQ, CESP, Gustave Roussy, Team "Exposome, Heredity, Cancer, and Health", INSERM, Paris-Saclay University, Paris-South University, Villejuif, France.
  • Kitahara CM; Unit of Cardiovascular and Nutritional Epidemiology, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.
  • Koh WP; Department of Biostatistics and Epidemiology, School of Public Health and Health Sciences, University of Massachusetts, Amherst, MA.
  • Linet MS; Division of Genetics and Epidemiology, The Institute of Cancer Research, London, United Kingdom.
  • Park HL; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD.
  • Lynch BM; Ontario Institute for Cancer Research, Toronto, ON, Canada.
  • May AM; Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada.
  • Mellemkjær L; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD.
  • Milne RL; Healthy Longevity Translational Research Programme, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
  • Palmer JR; Singapore Institute for Clinical Sciences, Agency for Science Technology and Research (A*STAR), Singapore, Singapore.
  • Ricceri F; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD.
  • Rohan TE; Department of Pathology and Laboratory Medicine, Department of Epidemiology, UC Irvine School of Medicine, Irvine, CA.
  • Ruddy KJ; Cancer Epidemiology Division, Cancer Council Victoria, Melbourne, VIC, Australia.
  • Sánchez MJ; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, VIC, Australia.
  • Shu XO; Physical Activity Laboratory, Baker Heart and Diabetes Institute, Melbourne, VIC, Australia.
  • Smith-Byrne K; Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.
  • Steindorf K; Danish Cancer Society Research Center, Copenhagen, Denmark.
  • Sund M; Cancer Epidemiology Division, Cancer Council Victoria, Melbourne, VIC, Australia.
  • Vachon CM; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, VIC, Australia.
  • Vatten LJ; Precision Medicine, School of Clinical Sciences at Monash Health, Monash University, Clayton, VIC, Australia.
  • Visvanathan K; Slone Epidemiology Center at Boston University, Boston, MA.
  • Weiderpass E; Department of Clinical and Biological Sciences, Centre for Biostatistics, Epidemiology, and Public Health, University of Turin, Turin, Italy.
  • Willett WC; Unit of Epidemiology, Regional Health Service ASL TO3, Turin, Italy.
  • Wolk A; Albert Einstein College of Medicine, Bronx, NY.
  • Yuan JM; Department of Oncology, Mayo Clinic, Rochester, MN.
  • Zheng W; Escuela Andaluza de Salud Pública (EASP), Granada, Spain.
  • Nichols HB; Instituto de Investigación Biosanitaria ibs.GRANADA, Granada, Spain.
  • Sandler DP; Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.
  • Swerdlow AJ; Department of Preventive Medicine and Public Health, University of Granada, Granada, Spain.
  • Schoemaker MJ; Division of Epidemiology, Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt Epidemiology Center, Vanderbilt University School of Medicine, Nashville, TN.
J Clin Oncol ; 42(8): 927-939, 2024 Mar 10.
Article em En | MEDLINE | ID: mdl-38079601
ABSTRACT

PURPOSE:

There is strong evidence that leisure-time physical activity is protective against postmenopausal breast cancer risk but the association with premenopausal breast cancer is less clear. The purpose of this study was to examine the association of physical activity with the risk of developing premenopausal breast cancer.

METHODS:

We pooled individual-level data on self-reported leisure-time physical activity across 19 cohort studies comprising 547,601 premenopausal women, with 10,231 incident cases of breast cancer. Multivariable Cox regression was used to estimate hazard ratios (HRs) and 95% CIs for associations of leisure-time physical activity with breast cancer incidence. HRs for high versus low levels of activity were based on a comparison of risk at the 90th versus 10th percentiles of activity. We assessed the linearity of the relationship and examined subtype-specific associations and effect modification across strata of breast cancer risk factors, including adiposity.

RESULTS:

Over a median 11.5 years of follow-up (IQR, 8.0-16.1 years), high versus low levels of leisure-time physical activity were associated with a 6% (HR, 0.94 [95% CI, 0.89 to 0.99]) and a 10% (HR, 0.90 [95% CI, 0.85 to 0.95]) reduction in breast cancer risk, before and after adjustment for BMI, respectively. Tests of nonlinearity suggested an approximately linear relationship (Pnonlinearity = .94). The inverse association was particularly strong for human epidermal growth factor receptor 2-enriched breast cancer (HR, 0.57 [95% CI, 0.39 to 0.84]; Phet = .07). Associations did not vary significantly across strata of breast cancer risk factors, including subgroups of adiposity.

CONCLUSION:

This large, pooled analysis of cohort studies adds to evidence that engagement in higher levels of leisure-time physical activity may lead to reduced premenopausal breast cancer risk.
Assuntos

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Neoplasias da Mama Limite: Female / Humans Idioma: En Revista: J Clin Oncol Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Reino Unido

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Neoplasias da Mama Limite: Female / Humans Idioma: En Revista: J Clin Oncol Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Reino Unido